Spots Global Cancer Trial Database for sintilimab + anlotinib + albumin paclitaxel + carboplatin
Every month we try and update this database with for sintilimab + anlotinib + albumin paclitaxel + carboplatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC | NCT04846452 | Metastatic NSCL... Recurrent NSCLC Advanced Non-Sm... | Sintilimab + An... Sintilimab + An... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University |